Epstein Secrets

better, sales on par with 2011 (trading -0.42%) • Redrow IMS looks ok, continues to make progress in tough & stable environment (trading -1.5%) • Publicis (unusually) reports very strong October organic growth, no Nov/Dec comment (trading +2.8%) • JC Decaux: Le Figaro reports that the digital business

CAT Barcap upgrades ORA, Jeff cuts JNJ/NKTR & upgrades SQNM (buy) MS upgrades TRIP & cuts IQNT CS downgrades JCP/VRTX, Baird upgrades NAV, JPM and Stifel downgrade STRA, Citi upgrades CMA Exane upgrades IHG LN, Citi downgrades RYA LN, Barclays initiates Russian Oil & Gas sector GS reits conviction bu

timates, sticks to outlook (trading -3.3%) • Atos Q1 revenues -1.8% versus estimate -1.4%, booking light, confirms 2104 outlook (trading -1.4%) • Publicis O1 organic growth beats estimates, reiterates 2014 growth target (trading +2.1%) • Akzo Nobel profit stagnates on revamp costs and fx, O1 sales mis

Raja downgrades HBAN • SunTrust initiates KRO (reduce), Citi downgrades MDP, PacCrest upgrades NFLX • Jefferies cuts NGLS/EPD, Baird upgrades SCTY, Stifel cuts R, Sterne Agee upgrades BOFI (buy) Europe Key Research: :••• Bofa downgrades SDRL NO/BAW SJ/ARTC DB & upgrades HTO GA (buy), Investec cuts DIA

+2.5% & Atlas Copco -2.6% on relatively inline quarters (tomorrow we will get #'s from Assa Abloy, Kone, Sandvik, SSAB). While strong numbers out of Publicis has Media names acting better. Bernanke goes in front of the Senate today @ 10am. SPA's — flat = 1676.70 last. ***Jobless Claims @ 8:30am, Philly F

ed/priced): UCP (UCP) 7.75M-shares priced at $15 (low-end), OncoMed Pharmaceuticals(OMED) 4.8M shares priced at $17 (above range) US Key Research: Stifel initiates Shippers — STNG/NNA/CPLP/TNP/ANW (buys) & DSX/NMM/CMRE (holds) & SSW (sell) ••• Wedbush initiates UA (op), Bernstein initiates FOXA (op),